We had a post on the report that Pepsi was using a flavor enhancement test that made use of embryonic cells from an aborted fetus. (NOT that they used that ingredient in their products!) In the discussion that ensued, it turned out that although the company Pepsi contracted with to do the testing had some patents using a Human Embryonic Kidney cells for this purpose, it wasn’t clear that these were used in the testing for Pepsi. At any rate, Pepsi has responded to the controversy and boycotts by vowing not to use testing involving fetal cells. The boycotts have been called off.
A pro-life group called off its yearlong boycott of Pepsi products Monday after the soft-drink giant provided assurances it would no longer use an aborted fetal-cell line to develop flavor enhancers.
Children of God for Life revealed last year that PepsiCo had contracted with Senomyx Inc., a San Diego biotech company that listed HEK-293, a “human embryo kidney” cell line produced from an aborted fetus in the 1970s, in more than 70 patents related to flavor enhancers.
“We are absolutely thrilled with PepsiCo’s decision,” Debi Vinnedge, executive director of Children of God for Life, said on the group’s website. “They have listened to their customers and have made both a wise and profound statement of corporate integrity that deserves the utmost respect, admiration and support of the public.”
In a letter to the group, Paul Boykas, PepsiCo vice president for global public policy, explained the company does no research that uses embryos or fetal cells and that Senomyx will not use the HEK line for Pepsi products.
Children of God for Life started its boycott effort, which had grown to include more than 30 pro-life organizations worldwide, last May and had engaged in a long back-and-forth with PepsiCo, during which the corporation denied using embryo or fetal tissue in various ways that pro-lifers dismissed as lawyerly spin.
But Mrs. Vinnedge told The Washington Times on Monday that the latest letter seemed evasion-proof.
“When they said they would not use HEK cell lines in their most recent letter – well, that is the hallmark for Senomyx research. So that was majorly different than what they had said in the past,” she explained.